Healthcare
What does a maximally fulfilling life look like?
Data 5, AI 5, Robot 3, Readiness 2 on the Industry Scorecard. Highest combined data + AI score of any industry. Lowest readiness tier. The gap between what AI can do and what the industry has adopted is the positioning window — but the sales cycle is the longest of any vertical.
Friction Map
| Friction | ABCD Maturity | Status | Opportunity |
|---|---|---|---|
| Prior authorization delays | AI | Not solved | Automation of insurance pre-auth. $31B admin waste annually. |
| Patient outcome fragmentation | AI + Cloud | Not solved | Outcome measurement layer across providers. Whoever owns this owns VBC. |
| EHR switching costs | Cloud | Entrenched | Epic/Cerner lock-in. Interoperability mandates (FHIR) creating cracks. |
| Clinical trial inefficiency | AI | Growing | AI-optimized protocols, patient matching, adaptive designs. |
| Remote patient monitoring | Devices + AI | Growing | Wearable DePIN sensors. Continuous data vs periodic visits. |
| Diagnostic uncertainty | AI | Growing | AI diagnostics matching specialist accuracy in imaging, pathology. |
| Drug discovery timeline | AI | Growing | 10-year cycles compressing. AI protein folding, molecular simulation. |
| Mental health access | AI + Cloud | Wide open | Behavioral health has shortest regulatory path and highest unmet demand. |
| Care coordination | Cloud | Wide open | No single system tracks "who is treating this patient." Graph problem. |
| Patient data sovereignty | Blockchain | Wide open | Patient-owned health records. DeSci protocols for consent and sharing. |
Three patterns:
- Wide-open gaps have shortest path to value: behavioral health, care coordination, patient data sovereignty
- Growing gaps require regulatory patience but compound: remote monitoring, diagnostics, drug discovery
- Entrenched friction (EHR lock-in) is the moat others built — attack at the edges (interoperability mandates)
Disruption Scoring
From the Disruption Matrix. Score: 0.57 — highest AI leverage of any industry but lowest wedge.
| Layer | Dimension | Score | Why |
|---|---|---|---|
| Wedge | Time to ACV | 1 | HIPAA, procurement committees, 12-18 months |
| Wedge | Universal JTBD % | 2 | CRM/workflow reusable. Clinical workflows, insurance coding are custom. |
| Moat | Collection Cost | 3 | Wearables growing. Clinical data requires consent and compliance. |
| Moat | Data Exclusivity | 4 | Patient outcome data fragmented and valuable. EHR vendors gate access. |
| Scale | AI Leverage | 5 | Diagnostics, drug discovery, treatment optimization. Highest of any industry. |
| Scale | Actuator Potential | 2 | AI recommends, doctor approves. Regulatory human-in-the-loop. |
The paradox: Highest AI leverage but lowest wedge. The industry knows AI will transform it but can't adopt it fast. This is why conviction is MEDIUM until sub-verticals are friction-mapped like Real Estate.
Sub-Verticals
Where the wedge is shortest:
| Segment | Regulatory Burden | Sales Cycle | Data Moat | Entry |
|---|---|---|---|---|
| Behavioral Health | Low | Short | High (outcome data) | Best |
| Home Health | Medium | Medium | High (continuous monitoring) | Good |
| Dental/Optometry | Low | Short | Medium | Good |
| Value-Based Care | High | Long | Very High (outcome attribution) | Hard |
| Specialty Pharmacy | Very High | Very Long | High | Hardest |
| Hospital Systems | Extreme | 18+ months | Extreme | Avoid |
Pearl Health ($2.5B) proved the VBC wedge: outcome-based pricing for primary care. Own the outcome measurement layer and the data compounds.
AI in Healthcare
| Domain | What Changes | Timeline |
|---|---|---|
| Clinical trials | AI-optimized protocols, patient matching, adaptive designs | Active |
| Diagnostics | Imaging, pathology, genomics matching specialist accuracy | Active |
| Drug discovery | Protein folding, molecular simulation compress 10-year cycles | 3-5 years |
| Precision medicine | Treatment adjusted to individual response in real-time | 5-10 years |
| Safety monitoring | Automated adverse event detection across real-world data | Active |
| Administrative | Prior auth automation, coding, documentation | Active |
Challenges
| Risk | Severity | Mitigation |
|---|---|---|
| Patient data privacy (HIPAA) | High | Encrypt at rest, patient-authorized access, ZK proofs for research |
| EHR interoperability | High | FHIR standards compliance, edge-based integration |
| Regulatory approval cycles | High | Start with lowest-regulated segments (behavioral, dental) |
| Liability for AI decisions | Medium | Human-in-the-loop requirement. AI assists, never decides. |
| Insurance reimbursement | Medium | Outcome-based models (VBC) align incentives with AI capabilities |
DeSci Protocols
What DeSci protocols create the data sovereign future?
- Secure, transparent and decentralized data management
- Data integrity and privacy via ZK proofs
- Patient-authorized data sharing between providers
- Supply chain verification for pharmaceuticals and devices
- Cryptographic patient consent on-chain
Marketplace
| Company | Wedge | Why Interesting |
|---|---|---|
| Pearl Health | VBC outcome pricing | $2.5B. Owns the outcome measurement layer. |
| athenadao | Women's health research | DeSci + community funding for underserved research |
| Forward Health Pods | AI-first primary care | Hardware + software removes human bottleneck |
| InsideTracker | Biomarker optimization | Consumer health data → personalized protocols |
Countries
Which countries' citizens live the most rewarding lives? See country analysis for the 25-dimension scoring framework.
Context
- Medical Science — The research frontier
- Industry Scorecard — Data 5, AI 5, Robot 3, Readiness 2
- Disruption Matrix — Wedge/Moat/Scale scoring framework
- DePIN — Sensor networks for continuous patient monitoring
- Data Footprint — Schema to feedback loop maturity
- Matrix Thinking — Where healthcare meets ABCD forces
Links
Questions
If healthcare has the highest AI leverage of any industry, why is it the hardest to sell into — and what does that reveal about where the real moat lives?
- Which sub-vertical has the shortest regulatory path AND the deepest data moat — and is that combination even possible?
- If patient data sovereignty becomes real (DeSci + ZK proofs), does the EHR lock-in moat collapse overnight or erode over a decade?
- What would a DePIN-first healthcare play look like — wearable sensors earning tokens for continuous health data?
- When AI diagnostics match specialist accuracy, does the value shift from diagnosis to treatment coordination — and who owns that layer?